Subscribe
shutterstock_1876891582_seda_yalova
21 December 2023Big PharmaMarisa Woutersen

BioNTech wins latest round in Covid-19 patent clash

CureVac suffers a blow following a favourable earlier opinion delivered by the German Federal Patent Court | Decision invalidates a patent related to mRNA tech.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
BioNTech and Pfizer challenge Moderna’s COVID-19 vaccine patent
29 August 2023   Inter partes review challenges broad claims and monopolisation over mRNA tech amidst existing legal dispute | Alnylam set to appeal separate court ruling against Moderna.
Big Pharma
Moderna, Pfizer and BioNTech hit with COVID-19 vaccine lawsuits over mRNA tech
8 June 2023   Promosome claimed it shared mRNA tech with the trio, who went on to make hugely successful vaccines | The small biotech wants a cut of more than $100 billion allegedly made by the big pharma companies.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

More on this story

Big Pharma
Moderna, Pfizer and BioNTech hit with COVID-19 vaccine lawsuits over mRNA tech
8 June 2023   Promosome claimed it shared mRNA tech with the trio, who went on to make hugely successful vaccines | The small biotech wants a cut of more than $100 billion allegedly made by the big pharma companies.
Big Pharma
BioNTech and Pfizer challenge Moderna’s COVID-19 vaccine patent
29 August 2023   Inter partes review challenges broad claims and monopolisation over mRNA tech amidst existing legal dispute | Alnylam set to appeal separate court ruling against Moderna.

More on this story

Big Pharma
Moderna, Pfizer and BioNTech hit with COVID-19 vaccine lawsuits over mRNA tech
8 June 2023   Promosome claimed it shared mRNA tech with the trio, who went on to make hugely successful vaccines | The small biotech wants a cut of more than $100 billion allegedly made by the big pharma companies.
Big Pharma
BioNTech and Pfizer challenge Moderna’s COVID-19 vaccine patent
29 August 2023   Inter partes review challenges broad claims and monopolisation over mRNA tech amidst existing legal dispute | Alnylam set to appeal separate court ruling against Moderna.

More features

Bayer gains exclusive licence for heart drug in Japan
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
GSK triumphs in EPO appeal, revoking Pfizer patent